Skip to main content
Top
Published in: Endocrine 3/2012

01-12-2012 | Research Letter

Resistin expression in human granulosa cells

Authors: Lennard P. Niles, Derek K. Lobb, Na Hyea Kang, Kristen J. Armstrong

Published in: Endocrine | Issue 3/2012

Login to get access

Excerpt

Resistin, also known as found in inflammatory zone 3 (FIZZ 3), is a cysteine-rich low molecular weight member of the FIZZ family of proteins. Resistin levels are elevated in obese mice, and those treated with the recombinant protein exhibit increased insulin resistance, whereas treatment with an antibody against resistin attenuated this condition [1]. Moreover, resistin expression is inhibited by thiazolidinediones which exert insulin-sensitizing effects via the peroxisome proliferator-activated receptor γ (PPARγ). On the basis of these findings, it was suggested that resistin may be a link between obesity and type-2 diabetes [1]. However, subsequent studies aimed at establishing a similar link between obesity, resistin levels, and type-2 diabetes in humans have been inconclusive [2]. Recent studies show that resistin is produced in the human placenta and its expression in the term placenta is significantly higher than that observed in the first trimester [3]. We have examined for the first time, the mRNA and protein expression of resistin in human granulosa cells obtained from patients undergoing fertility treatment. The mRNA expression of PPARγ, which is involved in the regulation of resistin gene transcription [4], was also examined. …
Literature
1.
go back to reference C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, M.A. Lazar, The hormone resistin links obesity to diabetes. Nature 409, 307–312 (2001)PubMedCrossRef C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, M.A. Lazar, The hormone resistin links obesity to diabetes. Nature 409, 307–312 (2001)PubMedCrossRef
2.
go back to reference M. Owecki, A. Miczke, E. Nikisch, D. Pupek-Musialik, J. Sowinski, Serum resistin concentrations are higher in human obesity but independent from insulin resistance. Exp. Clin. Endocrinol. Diabetes 119, 117–121 (2011)PubMedCrossRef M. Owecki, A. Miczke, E. Nikisch, D. Pupek-Musialik, J. Sowinski, Serum resistin concentrations are higher in human obesity but independent from insulin resistance. Exp. Clin. Endocrinol. Diabetes 119, 117–121 (2011)PubMedCrossRef
3.
go back to reference S. Yura, N. Sagawa, H. Itoh, K. Kakui, M.A. Nuamah, D. Korita, M. Takemura, S. Fujii, Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 88, 1394–1397 (2003)PubMedCrossRef S. Yura, N. Sagawa, H. Itoh, K. Kakui, M.A. Nuamah, D. Korita, M. Takemura, S. Fujii, Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 88, 1394–1397 (2003)PubMedCrossRef
4.
go back to reference A.K. Singh, A. Battu, K. Mohareer, S.E. Hasnain, N.Z. Ehtesham, Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One 5, e9912 (2010)PubMedCrossRef A.K. Singh, A. Battu, K. Mohareer, S.E. Hasnain, N.Z. Ehtesham, Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One 5, e9912 (2010)PubMedCrossRef
5.
go back to reference D.K. Lobb, E.V. Younglai, A simplified method for preparing IVF granulosa cells for culture. J. Assist. Reprod. Genet. 23, 93–95 (2006)PubMedCrossRef D.K. Lobb, E.V. Younglai, A simplified method for preparing IVF granulosa cells for culture. J. Assist. Reprod. Genet. 23, 93–95 (2006)PubMedCrossRef
6.
go back to reference L.M. Castro, M. Gallant, L.P. Niles, Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J. Neurochem. 95, 1227–1236 (2005)PubMedCrossRef L.M. Castro, M. Gallant, L.P. Niles, Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J. Neurochem. 95, 1227–1236 (2005)PubMedCrossRef
7.
go back to reference M. Degawa-Yamauchi, J.E. Bovenkerk, B.E. Juliar, W. Watson, K. Kerr, R. Jones, Q. Zhu, R.V. Considine, Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88, 5452–5455 (2003)PubMedCrossRef M. Degawa-Yamauchi, J.E. Bovenkerk, B.E. Juliar, W. Watson, K. Kerr, R. Jones, Q. Zhu, R.V. Considine, Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88, 5452–5455 (2003)PubMedCrossRef
8.
go back to reference B.A. Morash, D. Wilkinson, E. Ur, M. Wilkinson, Resistin expression and regulation in mouse pituitary. FEBS Lett. 526, 26–30 (2002)PubMedCrossRef B.A. Morash, D. Wilkinson, E. Ur, M. Wilkinson, Resistin expression and regulation in mouse pituitary. FEBS Lett. 526, 26–30 (2002)PubMedCrossRef
9.
go back to reference R. Nogueiras, R. Gallego, O. Gualillo, J.E. Caminos, T. Garcia-Caballero, F.F. Casanueva, C. Dieguez, Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 548, 21–27 (2003)PubMedCrossRef R. Nogueiras, R. Gallego, O. Gualillo, J.E. Caminos, T. Garcia-Caballero, F.F. Casanueva, C. Dieguez, Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 548, 21–27 (2003)PubMedCrossRef
10.
go back to reference M.A. Lazar, Resistin- and obesity-associated metabolic diseases. Horm. Metab. Res. 39, 710–716 (2007)PubMedCrossRef M.A. Lazar, Resistin- and obesity-associated metabolic diseases. Horm. Metab. Res. 39, 710–716 (2007)PubMedCrossRef
11.
go back to reference X.K. Wu, S.Y. Zhou, J.X. Liu, P. Pollanen, K. Sallinen, M. Makinen, R. Erkkola, Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil. Steril. 80, 954–965 (2003)PubMedCrossRef X.K. Wu, S.Y. Zhou, J.X. Liu, P. Pollanen, K. Sallinen, M. Makinen, R. Erkkola, Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil. Steril. 80, 954–965 (2003)PubMedCrossRef
12.
go back to reference V. Maillard, P. Froment, C. Rame, S. Uzbekova, S. Elis, J. Dupont, Expression and effect of resistin on bovine and rat granulosa cell steroidogenesis and proliferation. Reproduction 141, 467–479 (2011)PubMedCrossRef V. Maillard, P. Froment, C. Rame, S. Uzbekova, S. Elis, J. Dupont, Expression and effect of resistin on bovine and rat granulosa cell steroidogenesis and proliferation. Reproduction 141, 467–479 (2011)PubMedCrossRef
Metadata
Title
Resistin expression in human granulosa cells
Authors
Lennard P. Niles
Derek K. Lobb
Na Hyea Kang
Kristen J. Armstrong
Publication date
01-12-2012
Publisher
Springer US
Published in
Endocrine / Issue 3/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9734-8

Other articles of this Issue 3/2012

Endocrine 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.